Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines.
Saved in:
| Title: | Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines. |
|---|---|
| Authors: | Smith WJ; Vaccine Drug Product Development, Pharmaceutical Sciences and Clinical Supplies, Merck & Co., Inc., West Point, PA, 19486, USA. Electronic address: william_smith2@merck.com., Ahl PL; Vaccine Drug Product Development, Pharmaceutical Sciences and Clinical Supplies, Merck & Co., Inc., West Point, PA, 19486, USA., Wang B; Vaccine Drug Product Development, Pharmaceutical Sciences and Clinical Supplies, Merck & Co., Inc., West Point, PA, 19486, USA., Hamm M; Vaccine Analytical Research and Development, MRL, Merck & Co., Inc., West Point, PA, 19486, USA., Rustandi RR; Vaccine Analytical Research and Development, MRL, Merck & Co., Inc., West Point, PA, 19486, USA., Winters MA; Vaccine Process Research and Development, MRL, Merck & Co., Inc., West Point, PA, 19486, USA., Blue JT; Vaccine Drug Product Development, Pharmaceutical Sciences and Clinical Supplies, Merck & Co., Inc., West Point, PA, 19486, USA. |
| Source: | Vaccine [Vaccine] 2022 Jul 29; Vol. 40 (31), pp. 4182-4189. Date of Electronic Publication: 2022 Jun 07. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35688729 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Smith+WJ%22">Smith WJ</searchLink>; Vaccine Drug Product Development, Pharmaceutical Sciences and Clinical Supplies, Merck & Co., Inc., West Point, PA, 19486, USA. Electronic address: william&#95;smith2@merck.com.<br /><searchLink fieldCode="AU" term="%22Ahl+PL%22">Ahl PL</searchLink>; Vaccine Drug Product Development, Pharmaceutical Sciences and Clinical Supplies, Merck & Co., Inc., West Point, PA, 19486, USA.<br /><searchLink fieldCode="AU" term="%22Wang+B%22">Wang B</searchLink>; Vaccine Drug Product Development, Pharmaceutical Sciences and Clinical Supplies, Merck & Co., Inc., West Point, PA, 19486, USA.<br /><searchLink fieldCode="AU" term="%22Hamm+M%22">Hamm M</searchLink>; Vaccine Analytical Research and Development, MRL, Merck & Co., Inc., West Point, PA, 19486, USA.<br /><searchLink fieldCode="AU" term="%22Rustandi+RR%22">Rustandi RR</searchLink>; Vaccine Analytical Research and Development, MRL, Merck & Co., Inc., West Point, PA, 19486, USA.<br /><searchLink fieldCode="AU" term="%22Winters+MA%22">Winters MA</searchLink>; Vaccine Process Research and Development, MRL, Merck & Co., Inc., West Point, PA, 19486, USA.<br /><searchLink fieldCode="AU" term="%22Blue+JT%22">Blue JT</searchLink>; Vaccine Drug Product Development, Pharmaceutical Sciences and Clinical Supplies, Merck & Co., Inc., West Point, PA, 19486, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2022 Jul 29; Vol. 40 (31), pp. 4182-4189. <i>Date of Electronic Publication: </i>2022 Jun 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35688729 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2022.05.056 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4182 Titles: – TitleFull: Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Smith WJ – PersonEntity: Name: NameFull: Ahl PL – PersonEntity: Name: NameFull: Wang B – PersonEntity: Name: NameFull: Hamm M – PersonEntity: Name: NameFull: Rustandi RR – PersonEntity: Name: NameFull: Winters MA – PersonEntity: Name: NameFull: Blue JT IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 07 Text: 2022 Jul 29 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 40 – Type: issue Value: 31 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |